FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

15164611000001105: Prezista 600mg tablets (Janssen-Cilag Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
53551401000001110 Prezista 600mg tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
53551501000001114 Prezista 600mg tablets (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prezista 600mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Is a Darunavir 600mg tablets true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Is a Darunavir 600mg tablets false Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Darunavir true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Is a Darunavir 600mg tablets false Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Is a Prezista true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darunavir false Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Darunavir ethanolate false Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has active ingredient Darunavir false Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Is a Product containing precisely darunavir 600 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Prezista 600mg tablets (Janssen-Cilag Ltd) Has basis of strength substance Darunavir true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Prezista 600mg tablets (Janssen-Cilag Ltd) 60 tablet Has AMP True Prezista 600mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start